Pfizer PFE
NYSE PFE
$27.80 -0.32 (-1.14%)
At close: Oct 2, 2026 · 4:00 PM EDT

Pfizer (PFE) Selling, General & Administrative (2009 - 2026)

Updated

Pfizer's Selling, General & Administrative was $3.41 billion in Q2 2026, down 0.1% from $3.42 billion a year earlier but up 15.2% from the prior quarter.

Analysis

Pfizer (PFE) Selling, General & Administrative (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Pfizer's Selling, General & Administrative was $13.72 billion through Jun 28, 2026, down 1.7% year-over-year; for FY2025, it came in at $13.79 billion, down 6.4% from FY2024.

  • Selling, General & Administrative shows a five-year compound annual growth rate of 3.5% (FY2020 to FY2025).
  • In earlier years, Selling, General & Administrative was $14.73 billion in FY2024 (-0.3%), $14.77 billion in FY2023 (+8.0%), $13.68 billion in FY2022 (+7.7%) and $12.7 billion in FY2021 (+9.5%).
  • Quarterly Selling, General & Administrative has moved between $2.59 billion (Q1 2022) and $4.65 billion (Q4 2022) over five years.
  • Compared with a year earlier, Selling, General & Administrative has declined for seven straight quarters, with an average decline of 5.0% over the last seven quarters.
  • The best year-over-year quarter for Selling, General & Administrative over five years was Q1 2023 (growth of 31.8%); the worst was Q1 2025 (a decline of 13.3%).
  • Per Business Quant data, PFE's Selling, General & Administrative in the three quarters before Q2 2026 was $2.96 billion (Q1 2026), $4.16 billion (Q4 2025) and $3.19 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 6.43 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 3.63 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -5.65 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 1.92 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 3.41 Bn
10 Vertex Pharmaceuticals 128.38 Bn 100.39 Bn 2.84 Bn 582.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 28, 2026 3.41 Bn
Mar 29, 2026 2.96 Bn
Dec 31, 2025 4.16 Bn
Sep 28, 2025 3.19 Bn
Jun 29, 2025 3.42 Bn
Mar 30, 2025 3.03 Bn
Dec 31, 2024 4.27 Bn
Sep 29, 2024 3.24 Bn
Jun 30, 2024 3.72 Bn
Mar 31, 2024 3.50 Bn
Dec 31, 2023 4.58 Bn
Jul 2, 2023 3.50 Bn
Apr 2, 2023 3.42 Bn
Dec 31, 2022 4.65 Bn
Jul 3, 2022 3.05 Bn
Apr 3, 2022 2.59 Bn
Dec 31, 2021 4.10 Bn
Oct 3, 2021 2.90 Bn
Jul 4, 2021 2.92 Bn
Apr 4, 2021 2.78 Bn
API Access

Pfizer Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=PFE&period=max&api_key=YOUR_API_KEY